Codagenix

Codagenix

Codagenix

Designer Viruses ~ Vaccine Development ~ Synthetic Biology ~ Ultra Low Dose Influenza Vaccines ~ Customized Dengue
Type
B2c
Founded
2011
Raised
$26M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$20,000,000
Venture capital - 2020
Topspin Fund Topspin Partners Euclidean Capital +1
$3,000,000
Venture capital - 2017
Topspin Partners
Team Size
2
Employees
FinSMEs

Codagenix Raises $20M in Series B Funding

$20,000,000 Venture capital
TechCrunch

Codagenix raises $20 million for a new flu vaccine and other therapies

$2,000,000 Venture capital (Series A)
Xconomy

With $2M, Codagenix Becomes Accelerate LI’s First VC-Backed Grad

Funding Health